Sabra Health Care REIT Stock (NASDAQ: SBRA)

Sabra Health Care REIT (NASDAQ:SBRA) Stock, Quote.Headers.trade-ideas

Sabra Health Care REIT

Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.

homes-ai4

Equities

Large Cap

Macro Economic Events

Mid Cap

REIT

Sector ETFs

Small Cap

Econ #s

Economics

Federal Reserve

ETFs

Real Estate

CBRE

RDFN

iShares FTSE NAREIT Residential PLUS Capped Index Fund

SBRA

XLRE

Good news for US homebuyers as mortgage rates drop to lowest level since May 2023. Despite this, mortgage applications dip as buyers wait for Fed&#39;s future policy direction. Real estate sector up.

30-Year Mortgage Rates Hit 15-Month Low, But Applications Pull Back After Recent Spikes: Real Estate Stocks React Wednesday (CORRECTED)

Earnings

News

Penny Stocks

Markets

Analyst Ratings

Trading Ideas

CTRE

Medical Properties Trust, Inc. (NYSE: MPW) — also known as MPT — recently concluded the disposition of 11 freestanding emergency department (FSED), primary care, imaging and urgent care facilities in Colorado to University of Colorado Health (&#34;UCHealth&#34;) for $86 million.

Medical Properties Disposes of 11 Facilities to UCHealth

Long Ideas

Media

ASML

STLD

On CNBC’s &#34;Halftime Report Final Trades,&#34; Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s on the verge of 

Deere, ASML, Steel Dynamics And A Real Estate Stock: CNBC&#39;s &#39;Final Trades&#39;

Sabra Health Care REIT, Inc. - Common Stock

Sabra Health Care REIT Inc

Ratings for Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $17.75, with a high estimate of $20.00 and a low estimate of $16.00. This upward trend is evident, with the current average reflecting a 12.7% increase from the previous average price target of $15.75.
<img src="https://www.benzinga.com/files/images/story/2024/1726236032_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Sabra Health Care REIT among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Joseph</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$18.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$17.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Sabra Health Care REIT. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Sabra Health Care REIT compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Sabra Health Care REIT's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Sabra Health Care REIT's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SBRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Sabra Health Care REIT analyst ratings.</a>
<h2>About Sabra Health Care REIT</h2>
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
<h3>Financial Insights: Sabra Health Care REIT</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Sabra Health Care REIT's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.29% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 13.61%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Sabra Health Care REIT's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.87%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Sabra Health Care REIT's ROA stands out, surpassing industry averages. With an impressive ROA of 0.45%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Sabra Health Care REIT's debt-to-equity ratio is below the industry average. With a ratio of 0.9, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sabra Health Care REIT Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Citigroup analyst Nicholas Joseph upgrades Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) from Neutral to Buy and raises the price target from $17 to $20.

Upgrades

Price Target

Citigroup Upgrades Sabra Health Care REIT to Buy, Raises Price Target to $20

Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) with a Buy and raises the price target from $16 to $18.

Truist Securities Maintains Buy on Sabra Health Care REIT, Raises Price Target to $18

Editor's Note: This article has been updated to reflect that the data was released on Wednesday.
Positive news has emerged for U.S. homebuyers navigating the housing market, as the average interest rate on 30-year fixed-rate mortgages with conforming loan balances (up to $766,550) declined to 6.50% in the week ending Aug. 16, according to data released Wednesday by <a href="https://www.benzinga.com/topic/mortgages">the Mortgage Bankers Association. </a>
This represents the lowest level since early May 2023. The decrease in mortgage rates aligns with a dip in long-term Treasury yields, influenced by market expectations of multiple rate cuts from the Federal Reserve this year.
Last week, the 30-year Treasury yield dropped by 7 basis points, currently on track for a fourth straight month of declines. Month-to-date the long-dated Treasury bond has seen its yields tumble by about 25 basis points to the current 4.05%. 
<h3 class="wp-block-heading">Mortgage Applications Dip As Homebuyers Take A Breather</h3>
However, this rate drop did not translate into an increase in mortgage application activity. 
After two consecutive weeks of robust growth, mortgage applications fell sharply, signaling that many potential homebuyers are still in a holding pattern, likely waiting for more clarity on the Federal Reserve&#8217;s future policy direction, which could be hinted at during the upcoming Jackson Hole Symposium.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40466528/jackson-hole-preview-5-important-questions-ahead-of-jerome-powells-fed-speech">Jackson Hole Preview: 5 Important Questions Ahead Of Jerome Powell&#8217;s Fed Speech</a>
Despite the reduced 30-year fixed mortgage rate, overall mortgage applications saw a 10.1% decline compared to the previous week, partially erasing the robust 25% gain recorded over the prior two weeks.
Refinance applications, which tend to be more sensitive to fluctuations in interest rates, dropped by 15%, cutting into the 35% surge observed in the previous week.
Similarly, applications for home purchase mortgages fell by 5%, building on the 8% decline from the prior week. 
<h3 class="wp-block-heading">Thursday&#8217;s Real Estate Stock Movers </h3>
The broader real estate sector, as tracked by the Real Estate&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>), was up 0.3% during Thursday premarket trading, on track to notch the highest level since September 2022. 
The Top-performing stock within the XLRE ETF was CBRE Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>), up 1.1%.
Taking a closer look at mortgage-linked industries, the iShares Residential and Multisector Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REZ#NYSE">REZ</a>) was flat, after closing Tuesday at the highest level since mid-September 2022.
Major premarket gainers within the REZ ETF included Healthcare Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HR#NYSE">HR</a>), up 1.3%, Sabra Health Care REIT, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NYSE">SBRA</a>), up 1.1%, and Universal Health Realty Income Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHT#NYSE">UHT</a>), up 13%
Other mortgage sensitive stocks, such as Redfin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) and Zillow Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>), were 1.2% and 0.2% higher, respectively. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40481111/nasdaq-s-p-500-futures-edge-up-as-traders-look-ahead-to-fomc-minutes-strategist-flags-3-trends-that">Nasdaq, S&amp;P 500 Futures Edge Up As Traders Look Ahead To FOMC Minutes: Strategist Flags 3 Trends That Could Help Stocks Withstand Volatility</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) &mdash; also known as MPT &mdash; recently concluded the disposition of 11 freestanding emergency department (FSED), primary care, imaging and urgent care facilities in Colorado to University of Colorado Health (&quot;UCHealth&quot;) for $86 million. The move is in line with the company&#39;s capital-recycling strategy.
Reflecting positive sentiments, shares of MPW gained 5.34% on Aug 15 regular trading session on the NYSE.
The company plans to allocate the proceeds obtained from the transaction toward debt reduction and for general corporate purposes.
MPT follows a disciplined capital-recycling strategy, through which it disposes of non-core assets and redeploys the proceeds in premium asset acquisitions and accretive development projects.
In July 2024, MPT sold seven FSED facilities as well as one general acute hospital in Arizona to Dignity Health for approximately $160 million.
In April 2024, the company sold its 75% interest in five Utah hospitals to a new joint venture with an institutional investor for $886 million. This sale generated approximately $1.1 billion of total cash proceeds to MPT. During the same month, it closed on the sale of five facilities in California and New Jersey to Prime Healthcare for a total consideration of $350 million.
This healthcare real estate investment trust (REIT), engaged in the acquisition and development of healthcare facilities, has been making efforts to improve portfolio diversification with respect to the operator.
The company is focusing on the reduction of its exposure to troubled operators and enhancing its scope for stable cashflow generation. Moreover, the company&#39;s successful execution of more than $2.5 billion in liquidity transactions since the beginning of the year through Aug 8, 2024, strengthens its balance sheet position and places it well to fund its short-term liquidity requirements.
Last week, this Birmingham, AL-based REIT reported better-than-expected second-quarter 2024 results. The company reported Normalized Funds from Operations of 23 cents per share, surpassing the Zacks Consensus Estimate of 20 cents.
Over the past six months, shares of this Zacks Rank #1 (Strong Buy) company have gained 38.5% compared with the industry&#39;s growth of 9%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4a/74521.jpg?v=528813046" />
Image Source: Zacks Investment Research
<h3>Other Stocks to Consider</h3>
Some other top-ranked stocks from the healthcare REIT sector are CareTrust REIT (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctre#NYSE">CTRE</a>) and Sabra Healthcare REIT (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbra#NASDAQ">SBRA</a>).
The Zacks Consensus Estimate for CareTrust&#39;s 2024 FFO per share stands at $1.47, indicating an increase of 4.3% from the year-ago reported figure. CTRE sports a Zacks Rank #1 at present.
Sabra currently carries a Zacks Rank #2 (Buy).The Zacks Consensus Estimate for SBRA&#39;s 2024 FFO per share is pinned at $1.41, suggesting year-over-year growth of 6%.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
<a href="https://www.zacks.com/stock/news/2323336/medical-properties-mpw-disposes-of-11-facilities-to-uchealth?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2323336">To read this article on Zacks.com click here.</a>

Guidance

Sabra Sees FY24 AFFO $1.39-$1.42 Vs $1.37 Estimate

Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.34 by 2.94 percent. This is a 6.06 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $176.141 million which beat the analyst consensus estimate of $166.032 million by 6.09 percent. This is a 9.29 percent increase over sales of $161.166 million the same period last year.

Earnings Beats

Sabra Health Care REIT Q2 2024 FFO $0.35 Beats $0.34 Estimate, Sales $176.141M Beat $166.032M Estimate

Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) with a Buy and raises the price target from $15 to $16.

Truist Securities Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

A significant insider buy by Catherine Cusack, Director at Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>), was executed on May 23, and reported in the recent SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001492298/000186212824000026//Archives/edgar/data/1492298/000186212824000026/0001862128-24-000026-index.htm">U.S. Securities and Exchange Commission</a> on Thursday unveiled that Cusack made a notable purchase of 7,000 shares of Sabra Health Care REIT, valuing at $101,010.
The latest update on Friday morning shows Sabra Health Care REIT shares up by 1.73%, trading at $14.39.
<h3>Unveiling the Story Behind Sabra Health Care REIT</h3>
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
<h3>Unraveling the Financial Story of Sabra Health Care REIT</h3>
Positive Revenue Trend: Examining Sabra Health Care REIT's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 3.36% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 67.62%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Sabra Health Care REIT's EPS reflects a decline, falling below the industry average with a current EPS of 0.11.
</li>
</ul>
Debt Management: Sabra Health Care REIT's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.9.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: Sabra Health Care REIT's current Price to Earnings (P/E) ratio of 67.38 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 5.06 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 16.93, Sabra Health Care REIT demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001492298">Check Out The Full List Of Sabra Health Care REIT's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Eye On Growth: Catherine Cusack Adds $101K Of Sabra Health Care REIT Stock To Portfolio

Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) with a Sector Perform and raises the price target from $14 to $15.

Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $15

2024 GUIDANCE
Sabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):
<ul>
<li>Net Income: $0.53 - $0.57</li>
<li>FFO: $1.33 - $1.37</li>
<li>Normalized FFO: $1.34 - $1.38</li>
<li>AFFO: $1.38 - $1.42</li>
<li>Normalized AFFO: $1.39 - $1.43</li>
</ul>
Earnings guidance above assumes no 2024 acquisition or disposition activity.
Commenting on the first quarter's results, Rick Matros, CEO and Chair, said, "As has been evident for several quarters, Sabra's portfolio continues to grow stronger, whether looking at coverage, occupancy, or NOI. Trailing-twelve-month SNF coverage saw a healthy 0.06x increase sequentially, to 1.79x, when excluding the impact of Provider Relief Funds. Our SHOP portfolio continues to improve, and this quarter's results - which faced a challenging year-over-year comp - are in line with our expectations embedded in guidance. Our balance sheet remains strong and is poised to support future growth.
Although we have no new investments to discuss this quarter, the pipeline has improved and with what we are working on, we expect to announce new investments on our second quarter call."

Sabra Health Care REIT Sees FY24 Normalized AFFO $1.39-$1.43

Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.33 by 6.06 percent. This is a 2.94 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $166.75 million which beat the analyst consensus estimate of $159.88 million by 4.30 percent. This is a 3.36 percent increase over sales of $161.32 million the same period last year.

Sabra Health Care REIT Q1 FFO $0.35 Beats $0.33 Estimate, Sales $166.75M Beat $159.88M Estimate

On CNBC&rsquo;s &quot;<a href="https://www.cnbc.com/video/2024/03/25/final-trades-steel-dynamics-sabra-health-care-asml-holding-and-deere.html">Halftime Report Final Trades</a>,&quot; Jim Lebenthal of Cerity Partners said if you are looking for a stock that&rsquo;s on the verge of <a href="https://www.benzinga.com/news/earnings/24/02/37159985/why-heavy-equipment-maker-deere-shares-are-taking-a-hit-today"> breaking out, Deere &amp; Company (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/de#NYSE">DE</a>).
On March 25, Deere &amp; Company said former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29.
Stephen Weiss of Short Hills Capital Partners picked ASML Holding N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asml#NASDAQ">ASML</a>), saying that it&rsquo;s a great story.
On March 25, ASML reported transactions under its current share buyback program.
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC named Sabra Health Care REIT, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbra#NASDAQ">SBRA</a>), which has an 8.4% dividend yield.
On Feb. 27, Sabra Health Care REIT posted better-than-expected sales results for its fourth quarter.
Joseph M. Terranova of Virtus Investment Partners said Steel Dynamics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stld#NASDAQ">STLD</a>) is breaking out.
On March 15, Steel Dynamics provided first-quarter 2024 earnings guidance. The company said it expects EPS of $3.51 to $3.55 vs. street view of $3.35, expecting profitability from the steel operations to be meaningfully stronger Q/Q on higher shipments and earnings across the platform.
<h3>Price Action</h3>
<ul>
<li>Deere shares fell 0.2% to settle at $398.03 on Monday.</li>
<li>ASML shares fell 0.1% to close at $978.93 on Monday.</li>
<li>Sabra Health Care gained 1.2% to settle at $14.45 during Monday&rsquo;s session.</li>
<li>Steel Dynamics shares gained 0.1% to close at $144.15 on Monday.</li>
</ul>
Image: Shutterstock 
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/03/37908147/how-to-earn-500-a-month-from-td-synnex-stock-ahead-of-q1-earnings-report"> How To Earn $500 A Month From TD Synnex Stock Ahead Of Q1 Earnings Report </a>

Deere, ASML, Steel Dynamics And A Real Estate Stock: CNBC's 'Final Trades'

CNBC Halftime Report Final Trades: Steel Dynamics, Sabra Health Care REIT, ASML Holding, Deere & Company

Sabra Health Care REIT Sees FY24 Normalized AFFO $1.39-$1.43 Vs $1.38 Est.

Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) reported quarterly earnings of $0.33 per share which met the analyst consensus estimate. The company reported quarterly sales of $163.40 million which beat the analyst consensus estimate of $158.10 million by 3.35 percent. This is a 0.96 percent decrease over sales of $164.99 million the same period last year.

Sabra Health Care REIT Q4 2023 GAAP EPS $0.33, Inline, Sales $163.40M Beat $158.10M Estimate

Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) reported quarterly sales of $163.40 million which beat the analyst consensus estimate of $158.10 million by 3.35 percent. This is a 0.96 percent decrease over sales of $164.99 million the same period last year.

Sabra Health Care REIT Q4 Sales $163.40M Beat $158.10M Estimate

ACAD

ACHC

AESI

AHCO

AIRS

ALEC

ALHC

AMBA

AMBC

APLS

ARKO

ARQT

ARRY

ATEC

AXON

BCSF

BECN

BGFV

BMBL

BWXT

BYND

CAVA

CBRL

CIVI

CLDT

CLNE

CLVT

CMLS

COMP

CPNG

CRDO

CYTK

EBAY

EHTH

ESPR

FARO

FLYW

FOUR

FSLR

FULC

GDOT

GLPI

GMRE

GSX Techedu Inc. American Depositary Shares

GOTU

GPOR

HRZN

HSIC

HURN

ICCC

ICFI

ICUI

IMAX

IMXI

INGN

INSE

IPAR

JAMF

KIND

KURA

KVYO

LAZR

LGND

LGVN

Earnings Scheduled For February 27, 2024

Investors looking to own winning stocks need to know which sectors are outperforming other sectors when making purchase decisions. With real estate investment trusts (REITs), subsectors go in and out of favor based on economic news, earnings and technical indicators such as being overbought or oversold.
A few months ago, office REITs were trouncing other subsectors. However, over the last week, healthcare REITs have emerged as the new leader among REITs. The healthcare REIT sub sector was not a great overall performer in 2023, but things may be turning around in 2024.
Take a look at four healthcare REITs that have shown strong performance since the close of trading on Feb. 5.
Medical Properties Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) is a Birmingham, Alabama-based healthcare REIT that owns and operates 441 general acute care and other properties across the U.S. and in nine other countries, including locations in Europe and Australia. It has a portfolio valued at $19 billion, of which about 64% are general acute care hospitals. About two-thirds of its properties are in the United States.&nbsp;
Medical Properties Trust was one of the worst performing of all REITs in January, following its update on its largest tenant, Steward Health Care System. The share price fell more than 30% after Medical Properties said it's accelerating its efforts to recover uncollected rents from the fourth quarter of 2023 and outstanding loan obligations from Steward. Medical Properties also agreed to fund a new $60 million bridge loan to Steward, secured by preexisting collateral plus a new second lien on Steward's managed care business.
In addition, Steward said it would explore the possible sale or re-tenanting of certain hospital operations along with the divestiture of non-core operations. At the end of 2023, Steward still owed approximately $50 million to Medical Properties Trust.
Lately, Medical Properties Trust has been a hot stock, up 10.73% since Feb. 5. There has been no news or analyst upgrades, and its fourth-quarter earnings don't come out until Feb. 21, so perhaps it's just an oversold bounce.
Omega Healthcare Investors Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>) is a Hunt Valley, Maryland-based triple-net equity healthcare REIT that provides financing, capital and leasing to 69 operators of 862 senior housing, skilled nursing and assisted living facilities across 42 states throughout the U.S. and the United Kingdom. Omega Healthcare Investors has no part in the day-to-day management of these facilities, which are run by the operators.
On Jan. 30, Deutsch bank analyst Omotayo Okusanya initiated coverage on Omega Healthcare Investors with a Buy rating and announced a price target of $36.
On Feb. 7, Omega Healthcare reported its fourth-quarter operating results. Funds from operations (FFO) of $0.68 per share beat the analysts' estimate of $0.67 per share but was below FFO of $0.73 in the fourth quarter of 2022. Revenue of $239.32 million beat the estimates of $233.82 million and the fourth-quarter 2022 revenue of $144.85 million by 65.22%.
On the strength of its earnings report, Omega Healthcare is up 10.3% since Feb. 5.
Caretrust REIT Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRE#NYSE">CTRE</a>) is a San Clemente, California-based healthcare REIT, founded in 2013, that owns and leases senior housing, skilled nursing facilities (SNF) and assisted living facilities (ALF). As of Dec. 31, its long-term net-lease portfolio consisted of 207 properties across 25 states with 23 property operators. Skilled nursing facilities account for 71.5% of its portfolio, 8.8% is senior housing and the remaining 19.7% is multiservice campus.
On Jan. 31, RBC Capital Markets analyst Michael Carroll maintained an Outperform rating on Caretrust and lowered the price target from $25 to $24.
On Feb. 8, Caretrust reported fourth-quarter operating results. FFO of $0.36 was in line with estimates but a decrease from FFO of $0.38 in the same quarter a year ago. But revenue of $59.73 million was 11.61% above analyst estimates of $53.52 million and a 15.29% increase over revenue of $51.81 million in the fourth quarter of 2022.
Since Feb. 5, Caretrust has risen 10.32%. Investors were impressed with the fourth-quarter results.
Sabra Health Care REIT Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) is an Irvine, California-based healthcare REIT that as of Sept. 30 has 410 investments across the U.S. Its portfolio consists of senior nursing facilities (SNF), senior housing, behavioral health and specialty hospitals with eight-year weighted average lease terms (WALT). Signature Healthcare is its largest tenant, with a rent concentration of 9%.
Sabra CEO Rick Matros recently told analysts that occupancy gains and easing labor pressures are driving rent coverage higher and Medicaid reimbursements have also been increasing. Sabra sold 13 SNFs and two senior housing facilities during the third quarter with net proceeds used to reduce the outstanding balance on Sabra's revolving credit facility.
On Jan. 30, Deutsch bank analyst Omotayo Okusanya initiated coverage on Sabra Health Care with a Buy rating and announced a price target of $21. The following day, Jenny Harrington of Gilman Hill Asset Management also recommended it on CNBC.
Sabra Health Care has climbed 7% since Feb. 5.
Explore Opportunities Beyond REITs
While publicly traded REITs offer a convenient way to invest in real estate, we believe that some of the most compelling opportunities lie in the private market. Benzinga's <a href="https://www.benzinga.com/alternative-investments/real-estate">real estate offering screener</a> features a curated selection of private market real estate offerings from trusted platforms with a track record of strong returns.
Whether you&#8217;re an accredited or non-accredited investor, you can filter opportunities based on your investment criteria, including minimum investment, property type and target return. These offerings provide a unique chance to diversify your portfolio and tap into potential high-yield investments that are not available on public exchanges.
<a href="https://www.benzinga.com/alternative-investments/real-estate">Browse offerings</a>
Latest Private Market Offerings
<ul>
<li><a href="https://www.benzinga.com/alternative-investments/listing/horizon-village">Horizon Village</a>: Grocery-anchored shopping center located in Phoenix, AZ, with a target return of 12%.</li>
<li><a href="https://www.benzinga.com/alternative-investments/listing/coop-at-eado">COOP @ EaDo</a>: Class A multifamily development with a 99-year property tax exemption and a target return of 20.9%</li>
<li><a href="https://www.benzinga.com/alternative-investments/listing/multi-family-portfolio-fund">Multi-Family Portfolio Fund</a>: Portfolio of existing class &#8216;B &amp; C&#8217; multi-family assets in the West &amp; South Western United States and a minimum investment of only $500.</li>
</ul>
Discover these and other exclusive real estate investment opportunities on Benzinga's offering screener. Dive into the private market and uncover the potential for substantial returns beyond the public REIT market.

Healthcare REITs Showing Strong Performance In February

Friday marks the last chance for investors to receive the next dividend payout from Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of 30 cents per share. On Monday, Sabra Health Care REIT will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 30 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own SBRA as of the end of Friday's session are eligible to receive the 30 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on February 29, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Dividends

Friday Is Your Last Chance To Buy Sabra Health Care REIT Before The Dividend Payout

Omotayo Okusanya, an analyst from Deutsche Bank , maintained the Buy rating on Sabra Healthcare REIT (SBRA – Research Report). The associated price...

Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects

The Return Of Volatility

REITs keep reducing NAV discount amid an impending rally

Losers And Winners Of REIT Earnings Season

Wells Fargo analyst James Feldman maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report) today and set a price target of $16.00...

Sabra Healthcare REIT (SBRA) Gets a Hold from Wells Fargo

SRET Lost Half Of Its Value And Distribution In Less Than 10 Years

Here are the most attractive high-yield dividend stocks right now

Best Real Estate growth stocks as the sector is seeing a revival

Medical Properties Trust: Expect Shares To Keep Soaring, Trading Below Fair Value

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Sabra Health Care REIT

Sabra Health Care REIT (SBRA) Forecast

Sabra Health Care REIT (NASDAQ:SBRA) Stock, Quote.Headers.trade-ideas